Cloning and characterization of the canine receptor for advanced glycation end products

Gene

Volumn 369, Issue 1-2, 2006, Pages 45-52

  Murua Escobar, Hugo ^a   Soller, Jan T ^a,b   Sterenczak, Katharina A ^b   Sperveslage, Jan D ^b   Schlueter, Claudia ^b   Burchardt, Birgit ^b   Eberle, Nina ^a   Fork, Melanie ^a   Nimzyk, Rolf ^b   Winkler, Susanne ^b   Nolte, Ingo ^a   Bullerdiek, Jörn ^b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

Canis familiaris; Comparative genomics; HMGB1; Metastasis; RAGE; Receptor for advanced glycation end products

Indexed keywords

AMINO ACID; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CANCER; CELL MOTILITY; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; DOG; GENE EXPRESSION; GENOMICS; GLYCATION; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RODENT; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CHROMOSOME MAPPING; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; DOGS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

ANIMALIA; CANIS FAMILIARIS; RODENTIA;

EID: 33644658831     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2005.10.015     Document Type: Article

References (37)

1. B. Bartling, H.S. Hofmann, B. Weigle, R.E. Silber, and A. Simm Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma Carcinogenesis 26 2 2005 293 301
2. M. Breen, R. Thomas, M.M. Binns, N.P. Carter, and C.F. Langford Reciprocal chromosome painting reveals detailed regions of conserved synteny between the karyotypes of the domestic dog (Canis familiaris) and human Genomics 61 1999 145 155
3. G. Cataldegirmen RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB J. Exp. Med. 201 3 2005 473 484
4. P. Fischer, N. Holmes, H. Dickens, R. Thomas, M. Binns, and E. Nacheva The application of FISH techniques for physical mapping in the dog (Canis familiaris) Mamm. Genome 7 1996 37 41
5. M.T. Goova Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice Am. J. Pathol. 159 2001 513 525
6. M.A. Hofmann RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
7. M.A. Hofmann RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response Genes Immun. 3 2002 123 135
8. B.I. Hudson, M.H. Stickland, and P.J. Grant Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups Diabetes 47 1998 1155 1157
9. B.I. Hudson, M.H. Stickland, T.S. Futers, and P.J. Grant Effects of novel polymorphisms in the rage gene on transcriptional regulation and their association with diabetic retinopathy Diabetes 50 2001 1505 1511
10. H.J. Huttunen, and H. Rauvala Amphoterin as an extracellular regulator of cell motility: from discovery to disease Intern. Med. 255 3 2004 351 366
11. H.J. Huttunen, C. Fages, J. Kuja-Panula, A.J. Ridley, and H. Rauvala Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis Cancer Res. 62 2002 4805 4811
12. H. Ishiguro, N. Nakaigawa, Y. Miyoshi, K. Fujinami, Y. Kubota, and H. Uemura Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development Prostate 64 1 2005 92 100 (Jun 15)
13. K. Kankova, A. Vasku, D. Hajek, J. Zahejsky, and V. Vasku Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes Diabetes Care 22 1999 1745
14. K. Kankova Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status Metabolism 50 2001 1152 1160
15. C. Khanna, and K. Hunter Modeling metastasis in vivo Carcinogenesis 26 3 2005 513 523
16. D.W. Knapp, and D.J. Waters Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans Mol. Med. Today 3 1 1997 8 11
17. L. Liu, and K. Xiang RAGE Gly82Ser polymorphism in diabetic microangiopathy Diabetes Care 22 1999 646
18. L.F. Lue Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism Exp. Neurol. 171 2001 29 45
19. E.G. MacEwen Spontaneous tumours in dogs and cats: models for the study of cancer biology and treatment Cancer Metastasis Rev. 9 1990 125 136
20. P. Malherbe cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell surface scavenger receptors and Swedish mutant amyloid precursor protein Brain Res. Mol. Brain Res. 71 1999 159 170
21. H. Murua Escobar Molecular characterization of the canine HMGB1 Cytogenet. Genome Res. 101 1 2003 33 38
22. M. Neeper Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J. Biol. Chem. 267 1992 14998 15004
23. L. Park Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Nat. Med. 4 1998 1025 1031
24. D.F. Patterson, M.E. Haskins, and P.F. Jezyk Models of human genetic disease in domestic animals Adv. Hum. Genet. 12 1982 263 339
25. O. Poirier Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patients Diabetes 50 2001 1214 1218
26. N. Reimann An extended nomenclature of the canine Cytogenet. Cell Genet. 73 1996 140 144
27. T. Sasahira, Y. Akama, K. Fujii, and H. Kuniyasu Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas Virchows Arch. 446 4 2005 411 415
28. C. Schlueter, S. Hauke, A.M. Flohr, P. Rogalla, and J. Bullerdiek Tissue-specific expression patterns of the RAGE receptor and its soluble forms-a result of regulated alternative splicing? Biochim. Biophys. Acta 1630 1 2003 1 6
29. A.M. Schmidt RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response Genes Immun. 3 2002 123 135
30. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J. Clin. Invest. 108 2001 949 955
31. A. Simm, C. Casselmann, A. Schubert, S. Hofmann, A. Reimann, and R.E. Silber Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction Exp. Gerontol. 39 3 2004 407 413
32. A. Taguchi Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 405 2000 354 360
33. V. Vasku Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis Arch. Dermatol. Res. 294 2002 127 130 (JID-8000462)
34. S.J. Withrow, and E.G. MacEwen Clinical Veterinary Oncology 1989 J.B. Lippincott, Co.
35. S.J. Withrow, and E.G. MacEwen Small Animal Clinical Oncology 2001 W.B. Saunders Company
36. S.D. Yan Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 5296 5301
37. F. Yang A complete comparative chromosome map for the dog, red fox, and human and its integration with canine genetic maps Genomics 62 1999 189 202